News & Events
Avvio Medical to Present Clinical Trial Results at the 2025 American Urological Association Annual Meeting
April 25, 2025 | Uncategorized
Moderated Interactive Poster Session to Feature AEROLITH RCT Data on Acoustic Enhancer Microbubble Cavitation with Ureteroscopic Laser Lithotripsy San Francisco,…Applaud Medical Changes Name to Avvio Medical, Ushering in a New Era of Kidney Stone Treatment
July 16, 2024 | Press Release
San Francisco, California – Avvio Medical, Inc. (formerly Applaud Medical), a company dedicated to revolutionizing the treatment of urinary stones, today…
Favorable Clinical Data for Applaud Medical’s Novel Technology for Treating Urinary Stones Presented During the 2024 AUA Annual Meeting
May 6, 2024 | Press Release
San Francisco, California – Applaud Medical, an emerging leader in the treatment of urinary stones, today announced positive results from a…Applaud Medical Appoints Paul Molloy as Chief Executive Officer and a Member of the Company’s Board of Directors
January 11, 2023 | Press Release
SAN FRANCISCO--Applaud Medical, an emerging leader in the treatment of urinary stone disease, announced today the appointment of industry veteran…Applaud Medical Receives FDA Breakthrough Device Designation for the Company’s Acoustic Enhancer for Use in Conjunction With Ureteroscopy With Laser Lithotripsy (URS-LL) for the Fragmentation of Calcium-Based Kidney Stones
January 31, 2022 | Press Release
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that its Acoustic Enhancer technology has…Applaud Medical Completes Series B Funding Round
October 28, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today confirmed that it had successfully…Applaud Medical selected by MedTech Innovator as one of Top 50 Medtech Startups
June 15, 2021 | News
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies…Applaud Medical Announces First Patient Enrolled in IDE Study
June 3, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced announced enrollment of the…Applaud Medical Granted New U.S. Patent for the Company’s Acoustic Enhancer Technology
March 23, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that a new U.S.…Applaud Medical Announces Approval of Investigational Device Exemption (IDE) for Pivotal Study
September 8, 2020 | News
SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced it has received approval…
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision O, April 2025.